Business
Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term
About this update from Medacta Group Sa
Medacta Group SA / Key word(s): Annual Results/Annual Results Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance 13-March-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Media Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance FY 2025 revenue accelerated to Euro 683.8 million, up 18.5% in c.c.1 or 15.8% in Euro Adjusted EBITDA grew by 19.1% to Euro 190.8 millionAdjusted EBITDA margin advanced to 29.0% in c.c. 1 up 190 bps yoyNet profit rose by 31.0% yoy to Euro 95.5 million incl. one-off gainsOperating cash flow grew by 42.5% to Euro 152.7 millionThe Board of Directors is proposing a distribution of CHF 1.10 per share (2024: CHF 0.69), an increase of 59.4% yoyOutlook 2026: Medacta is targeting a revenue growth in the range of 10% to 14% in constant currency and an expansion of the adjusted EBITDA margin of around 50bps vs. the prior year (27.9%), in constant currency, subject to unforeseen events.Mid-term outlook: Revenue compound annual growth rate (CAGR) (2024–2027E) in constant currency is expected to range between 12% and 15%, with a gradual improvement of the adjusted EBITDA margin vs. 2025, in constant currency, subject to unforeseen events. CASTEL SAN PIETRO, 13 March 2026 – Medacta Group SA (“Medacta”, SIX: MOVE) today announces its full year 2025 results. Francesco Siccardi, CEO of Medacta, commented: “I am very pleased to report another year of strong organic sales growth in the high teens, together with a significant expansion of our adjusted EBITDA margin. These industry leading results confirm the unique position of Medacta. Our vigorous focus on differentiating innovations for minimally invasive techniques and personalized solutions, the surgeon-specific structured medical education and the constant expansion of our sales force are the key pillars of our successful strategy. I thank the entire Medacta team for its efforts in delivering such excellent results.” Our achievements in 2025 2025 marks Medacta’s 10 years of success of ...